DQIS — Register of Scientific Objections v20

Supplementary document to the DQIS Consolidated Framework v22. 0 (Zenodo DOI: 10. 5281/zenodo. 19855263). Register of scientific objections identified during preparation for academic validation of the DQIS framework — Distributed Quantum-Inspired Immune Surveillance. 22 objections addressed across five categories: mathematical, biological, engineering, clinical, and empirical. Version 20. 0 (May 2026) — principal updates: O18 RESOLVED with direct empirical measurements (GBM θ=0. 199 on 7, 911 real cells; PDAC θ=1. 214 on 11, 448 real cells). O20 RESOLVED — datasets downloaded and analysed. O21 added: normal pancreas intrinsically cold (θ=1. 107) — biological explanation (PDX1/HNF1B/PTF1A). O22 added: IPS module resolves PDAC — 15. 5× penetrance signal, P (false alarm) =0. 0003. O10 corrected: sensitivity table now uses correct k=3 Monte Carlo values (prior v11. 0 k=5 values were erroneous). Status by objection: O1 — pᵢ empirical grounding: T-γ* and T-δ on target with existing technology; T-β pᵢ=0. 004 median (AND-gate M/E, Monte Carlo 10, 000 iterations) ; T-α v3. 0 pᵢ=0. 0003–0. 002 (triple-AND-gate, best channel in system). O2 — Channel independence: empirically validated GSE72056; inter-M/E LTD≈0; θ=0. 17 canonical; balanced quorum eliminates mTOR hub by construction. O3 — Population-level selective pressure: O3-A structurally mitigated by Pattern Drift Sensor; O3-B (global coordination) open as infrastructure requirement. O4 — T-ε reachability pᵢ=0. 01: histotype-dependent; already on target for HER2+/EGFR-amplified. O5 — DQIS-J paediatric procedures: resolved v14. 0 — 2 lifetime procedures; self-sustaining threshold effect. O6 — T-γ* temporal criterion: resolved — NFAT-like integrator, 3–4 brief contacts to threshold. O7 — CHIP clonal drift: managed — pre-infusion conditioning + cfDNA barcoding every 12–18 months + selective iC9 reset. O8 — Epigenetic transgene silencing: OPEN — SFFV+AAVS1-intron1+150bp computationally optimal; T-cell organoid validation required before Phase I. O9 — Pquorum in TME: RESOLVED v12. 0 — transit model; Pquorum ≥99. 93% all tumor phases; detection threshold N~3×10³ cells. O10 — Bulk vs single-cell correlations: corrected v13. 0 — ρₛc ≤ ρbulk for inter-group pairs; θ=0. 17 is upper bound; k=3 Monte Carlo is correct reference. O11 — Ci-VSP immunogenicity: resolved Phase 0 — H→Q mutation recommended before Phase I; partially open for Phase I. O12 — CDIC dormant cells: managed — T-δ and T-ε cover structurally; pregnancy contraindication for CDIC mode (Medium/High profiles only). O13 — HLA silencing and NK missing self: resolved — HLA-E in construct; pool 6. 7× above threshold. O14 — Penn Medicine data transferability to children: partially resolved — Nₛs 5–9× above threshold computationally; preclinical mouse model required before Phase I. O15 — Brain reporter gap: RESOLVED v14. 0 — Sₜm + hepatic S₂ cascade; blue urine 11–24h from brain. O16 — T-α self-activation: RESOLVED MATHEMATICALLY — triple-AND-gate v3. 0; pᵢ=0. 0003–0. 002 from literature. O17 — Tonic signaling exhaustion: RESOLVED MATHEMATICALLY — PAA ε (10y) =0. 921; doxycycline+tet-on analytically proven. O18 — θ cold tumors: RESOLVED WITH DATA — GBM θ=0. 199 (NOT cold) ; PDAC θ=1. 214 (confirmed cold) ; IPS resolves PDAC. O19 — Magenta Therapeutics closure: RESOLVED — replaced with Jasper Therapeutics (briquilimab, Phase 1b Nature Medicine 2025). O20 — Data access bottleneck: RESOLVED — datasets downloaded and analysed May 2026. O21 — Normal pancreas intrinsically cold: RESOLVED — biological explanation; IPS discriminates where θ cannot. O22 — IPS module PDAC detection: RESOLVED — 15. 5× penetrance signal; IPMN early warning 10. 1×; P (false alarm) =0. 0003; no construct modification required. No open structural flaws. O8 (epigenetic silencing) and O14 (paediatric data transferability) require standard preclinical validation, not conceptual breakthroughs. Not a peer-reviewed publication. Prior art deposit — CC BY 4. 0. Contact: dqis. research@proton. meRelated documents: - DQIS Consolidated Framework (main document): https: //zenodo. org/records/19877553 - Addendum I — Temporal Stratification of Tail Dependence Risk: https: //zenodo. org/records/19877810